|
PHOSPHO2 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.72955008490317E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73339120834726E-12 |
| Normal-vs-Stage2 |
4.53650450538134E-11 |
| Normal-vs-Stage3 |
5.65103519534205E-14 |
| Normal-vs-Stage4 |
1.62558855265615E-12 |
| Stage1-vs-Stage2 |
9.503800E-01 |
| Stage1-vs-Stage3 |
6.585800E-01 |
| Stage1-vs-Stage4 |
2.858000E-02 |
| Stage2-vs-Stage3 |
8.595200E-01 |
| Stage2-vs-Stage4 |
1.702350E-01 |
| Stage3-vs-Stage4 |
8.564300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.33146835171283E-14 |
| Normal-vs-AfricanAmerican |
1.88600002282158E-09 |
| Normal-vs-Asian |
3.88080001467728E-09 |
| Caucasian-vs-AfricanAmerican |
8.495500E-02 |
| Caucasian-vs-Asian |
7.402200E-02 |
| AfricanAmerican-vs-Asian |
9.639600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.88178419700125E-16 |
| Normal-vs-Female |
2.31481500634345E-13 |
| Male-vs-Female |
9.618800E-04 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66044955562938E-12 |
| Normal-vs-Age(41-60Yrs) |
1.38333788868295E-13 |
| Normal-vs-Age(61-80Yrs) |
1.59872115546023E-14 |
| Normal-vs-Age(81-100Yrs) |
3.019200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.168600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.242200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.343200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.101400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.933600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.949000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.728760E-01 |
| Classical-VS-Follicular |
4.515800E-01 |
| Classical-VS-Other |
4.786600E-01 |
| Classical-VS-Normal |
1.0502709812954E-13 |
| Tall-VS-Follicular |
6.518200E-02 |
| Tall-VS-Other |
9.879000E-01 |
| Tall-VS-Normal |
1.31006316905768E-14 |
| Follicular-VS-Other |
4.325800E-01 |
| Follicular-VS-Normal |
3.01725311402379E-12 |
| Other-VS-Normal |
1.554400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.05755420981768E-13 |
| Normal-vs-N1 |
4.44089209850063E-15 |
| N0-vs-N1 |
5.433800E-02 |
|
|
